Skip to main content
SpringerLink
Log in

Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines

  • Short Communication
  • Melanoma, Chemotherapy, Cytokines, TNFα, Isolated Perfusion
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion (P<0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval (P<0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Balkwill FR, Lee A, Aldom G, Moodie E, Thomas JA, Tavernier J, Fiers W (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res 46:3990

    PubMed  Google Scholar 

  2. Beutler B, Cerami A (1988) Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57:505

    PubMed  Google Scholar 

  3. Butler J, Long Chong G, Rocker GM (1992) Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 53:833

    PubMed  Google Scholar 

  4. Calabresi P, Chabner BA (1990) Antineoplastic agents. In: Goodman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon, New York, p 1209

    Google Scholar 

  5. Castell JV, Gómez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC (1989) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237

    PubMed  Google Scholar 

  6. Creech O Jr, Krementz ET, Ryan RE, Winblad JN (1958) Chemotherapy of cancer, regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616

    PubMed  Google Scholar 

  7. Donnelly SC, Strieter RM, Haslett C (1993) Interleukin 8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643

    PubMed  Google Scholar 

  8. Edwards MJ, Soong S-J, Boddie AW, Balch CM, McBride CM (1990) Isolated limb perfusion for localized melanoma of the extremity: a matched comparison of wide local excision with isolated limb perfusion and wide local excision alone. Arch Surg 125:317

    PubMed  Google Scholar 

  9. Fischer C, Gill C, Forrester MG, Nakamura R (1976) Quantitation of “acute phase proteins” postoperatively: value in detection and monitoring of complications. Am J Clin Pathol 66:840

    PubMed  Google Scholar 

  10. Gerulath AH, Loo TL (1972) Mechanism of action of 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide in mammalian cells in culture. Biochem Pharmacol 21:2335

    PubMed  Google Scholar 

  11. Hafström L, Rudenstam CM, Blomquist E, Ingvar C, Jönsson PE, Lagerlöf B, Lindholm C, Ringborg U, Westman G, Ostrup L (1991) Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J Clin Oncol 9:2091

    PubMed  Google Scholar 

  12. Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265:621

    PubMed  Google Scholar 

  13. Krementz ET, Ryan RF, Carter RD, Sutherland CM, Reed RJ (1985) Hyperthermic regional perfusion for melanoma of the limbs: In: Balch CM, Milton GW (eds) Cutaneous melanoma: clinical management and treatment results worldwide. Lippincott, Philadelphia, p 171

    Google Scholar 

  14. Le J, Vilcek J (1989) Interleukin 6 a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 61:588

    PubMed  Google Scholar 

  15. Lefor AT, Foster CE III, Sartor W, Engbrecht B, Fabian DF, Silverman D (1994) Hyperthermia increases the cell surface expression and secretion of ICAM-1 by human umbilical vein endothelial cells. Surgery 116:214

    PubMed  Google Scholar 

  16. Lienard D, Lejeune F (1992) High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10:52

    PubMed  Google Scholar 

  17. Marinkovic S, Jahreis GP, Wong GG, Baumann H (1989) IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808

    PubMed  Google Scholar 

  18. Martijn H, Schraffordt Koops H, Milton GW, Nap M, Oosterhuis JW, Shaw HM, Oldhoff J (1986) Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities: wide surgical excision with and without adjuvant regional perfusion. Cancer 57:1923

    PubMed  Google Scholar 

  19. Mizuno NS, Humphrey EW (1972) Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue. Cancer Chemother Rep 56:465

    PubMed  Google Scholar 

  20. Mocek FW, Austin EH, Miller FN, Edwards MJ (1995) Interleukin-6 and interleukin-8: elevated circulating levels following pediatric cardiac surgery. J Thorac Cardiovasc Surg (in press)

  21. Morrone G, Ciliberto G, Oliviero S, Arcone R, Dente L, Content J, Cortese R (1988) Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem 263:12554

    PubMed  Google Scholar 

  22. Perlmutter DH, Dinarello CA, Punsai PI, Colten HR (1986) TNF regulates hepatic acute phase gene expression. J Clin Invest 78:1349

    PubMed  Google Scholar 

  23. Saunders PP, Chao LY (1974) Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells. Cancer Res 34:2464

    PubMed  Google Scholar 

  24. Skibba JL, Bryan GT (1971) Methylation of nucleic acids and urinary excretion of14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole5(4)-carboxomide. Toxicol Appl Pharmacol 18:707

    PubMed  Google Scholar 

  25. Stehlin JS, Clark L (1965) Melanoma of the extremities: experiences with conventional treatments and perfusion in 339 cases. Am J Surg 110:366

    PubMed  Google Scholar 

  26. Stehlin JS, Giovanella BC, Ipolyi PD de, Muenz LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140:339

    PubMed  Google Scholar 

  27. Vaglini M, Belli F, Marolda R, Santinami M, Cascinelli N (1987) Hyperthermic antiplastic perfusion with dacarbazine in stage IIIA-IIIAB melanoma of the extremities. Eur J Surg Oncol 13:127

    PubMed  Google Scholar 

  28. Wortel CH, Deventer SJ van, Aarden LA, Lygidakis NJ, Buller HR, Hoek FJ, Horikx J (1993) Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 114:564

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, University of Louisville, School of Medicine, 40292, Louisville, KY, USA

    Terre D. Quinn, Hiram C. Polk Jr. & Michael J. Edwards

  2. James Graham Brown Cancer Center, 40292, Louisville, KY, USA

    Terre D. Quinn, Hiram C. Polk Jr. & Michael J. Edwards

Authors
  1. Terre D. Quinn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiram C. Polk Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quinn, T.D., Polk, H.C. & Edwards, M.J. Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines. Cancer Immunol Immunother 40, 272–275 (1995). https://doi.org/10.1007/BF01519902

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01519902

Key words

Search

Navigation